Deck Kelly 4
4 · Inhibrx, Inc. · Filed Mar 12, 2024
Insider Transaction Report
Form 4
Inhibrx, Inc.INBX
Deck Kelly
Chief Financial Officer
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2024-03-08$35.75/sh−42,523$1,520,197→ 38,020 totalExercise: $10.52Exp: 2028-11-26→ Common Stock (42,523 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the total shares subject to the stock option became exercisable on November 26, 2019, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter.